# Ketamine Use in a Laboring Mother With Type 4 Ehlers-Danlos Syndrome, a Family History of Malignant Hyperthermia, and Opioid-Induced Seizures

**Authors:** Ryan I Bower, Ian W McArdle, Arpan Kohli, Merv Unger

PMC · DOI: 10.7759/cureus.87471 · Cureus · 2025-07-07

## TL;DR

A high-risk pregnant woman with a rare connective tissue disorder and seizure history safely used ketamine for pain during childbirth.

## Contribution

Demonstrates the safe use of ketamine for labor analgesia in a patient with type 4 EDS and opioid-induced seizure risk.

## Key findings

- Ketamine infusion provided effective labor analgesia without complications.
- The patient delivered a healthy neonate with no adverse outcomes.
- Traditional analgesia methods were too risky due to the patient's medical history.

## Abstract

Ehlers-Danlos Syndrome (EDS) is a group of inherited, autosomal dominant connective tissue disorders caused by defects in procollagen and collagen production. Vascular EDS, also known as type 4 EDS, involves mutations in the COL3A1 gene, resulting in fragile vascular tissues and compromised organ integrity, which pose significant challenges during both labor and anesthesia. We report the case of a 19-year-old female patient with type 4 EDS, opioid-induced seizures, and a family history of malignant hyperthermia, who presented to the labor ward at 37 weeks of gestation. Due to her complex medical history, traditional methods for labor analgesia, including neuraxial techniques and remifentanil patient-controlled analgesia, were associated with significantly increased risks. A tailored pain management regimen was implemented, consisting of intravenous acetaminophen, cyclobenzaprine, and a ketamine infusion. The patient delivered a healthy neonate without complications. This case highlights the successful use of ketamine for labor analgesia in a high-risk obstetric patient with EDS.

## Linked entities

- **Genes:** COL3A1 (collagen type III alpha 1 chain) [NCBI Gene 1281]
- **Chemicals:** acetaminophen (PubChem CID 1983), cyclobenzaprine (PubChem CID 2895), ketamine (PubChem CID 3821), remifentanil (PubChem CID 60815)
- **Diseases:** Ehlers-Danlos Syndrome (MONDO:0020066), vascular EDS (MONDO:0017314), malignant hyperthermia (MONDO:0018493)

## Full-text entities

- **Genes:** COL3A1 (collagen type III alpha 1 chain) [NCBI Gene 1281] {aka EDS4A, EDSVASC, PMGEDSV}
- **Diseases:** Vascular EDS (MESH:D000094623), EDS (MESH:D004535), inherited, autosomal dominant connective tissue disorders (MESH:C535910), Seizures (MESH:D012640), pain (MESH:D010146), Malignant Hyperthermia (MESH:D008305)
- **Chemicals:** remifentanil (MESH:D000077208), acetaminophen (MESH:D000082), Ketamine (MESH:D007649), cyclobenzaprine (MESH:C004704)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12327914/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12327914/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12327914/full.md

---
Source: https://tomesphere.com/paper/PMC12327914